Skip to main content
letter
. 2017 Jun 2;7(6):e566. doi: 10.1038/bcj.2017.42

Figure 2.

Figure 2

Chimerism timelines in patients with persistent complete PB DC and incomplete BM DC. DC following primary allogeneic stem cell transplantation (HSCT, t=0) for 8 individual patients with persistent mismatched complete PB/incomplete BM DC status (ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; MPN, myeloproliferative neoplasm). Vertical lines represent the time points of second HSCT (t), relapse-related death (†) or evident molecular relapse (mr).